STAT

BIO in 30 Seconds

Dispatches from the BIO International Convention in San Diego.

We are on the ground in San Diego! Follow us on Twitter for more updates: @damiangarde@rebeccadrobbins@megkesh, and of course, @statnews

Making up for past snubs

Massachusetts Gov.(which is basically an extension of his predecessor’s 10-year, $1 billion program to promote life sciences). He’ll also be trying to get a sense of how these BIO bashes work: Boston is slated to host next year’s confab.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks